Ono Pharmaceutical (OTCMKTS:OPHLY) Trading 0.2% Higher – Time to Buy?

Shares of Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) traded up 0.2% during mid-day trading on Monday . The company traded as high as $5.07 and last traded at $5.07. 14,364 shares changed hands during trading, a decline of 45% from the average session volume of 26,150 shares. The stock had previously closed at $5.06.

Ono Pharmaceutical Trading Up 0.2%

The business’s fifty day simple moving average is $5.25 and its 200-day simple moving average is $4.72.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and marketing of prescription drugs and diagnostics. Headquartered in Osaka, the company traces its origins to the early 18th century and has grown into a global specialty‐pharmaceutical firm. Its product portfolio spans oncology, immunology, allergy and inflammatory diseases, with a notable focus on novel immunotherapies.

In oncology, Ono Pharmaceutical is best known for co‐developing and commercializing nivolumab (Opdivo), an anti–PD‐1 immune checkpoint inhibitor developed in partnership with Bristol‐Myers Squibb.